Introduction
A number of mechanisms have been suggested to explain the selective destruction of beta cells by alloxan which leads to permanent diabetes. None of these mechanisms however, has been accepted due to lack of convincing evidences.
S t r e c k e r 1 showed th a t in aqueous media alloxan oxidatively degrades a-amino acids to carbonyl compounds with one less carbon atom (RCHNH2^ RCHO). A number of compounds, other than alloxan were found to affect the S t r e c k e r degrada tion of a-amino acids2-5. This reaction has never been demonstrated to take place in blood. B r u c km a n n 6 stated th at the S t r e c k e r reaction could hardly be responsible for the diabetogenic action of alloxan because of two reasons: (a) the reaction requires hours for completion whereas alloxan damage is histologically demonstrable few minutes after injection, and (b) other compounds are active agents in the S t r e c k e r reaction, e.g. ninhydrin, but are not diabetogenic. In the present work it seemed worthwhile to investigate the effect of alloxan and ninhydrin on amino acids in aqueous buffered solution at pH 7, and in blood both in vitro and in vivo. Furthermore experiments were carried out to find if the S t r e c k e r reaction is given by alloxanic acid.
R equests for reprints should be sent to Dr. D . H . A known weight of solid alloxan, alloxanic acid or ninhydrin was dissolved in 5 ml of a phosphate buffer of pH 7 followed quickly by 2 ml alanine solution and the volume was completed to 10 ml by distilled water. A current of CO2 was then passed through the solution to expel the air, the tubes were closed and put in a therm ostated room a t 25 °C, the constancy of tem perature wras ± 2 °C. At different intervals, samples of the solutions were withdrawn and the unreacted alanine was determined using the modified V i r t a n e n 's procedure7. The same reac tions wrere carried out by bubbling air through the reaction medium (80 bubbles per minute) and the unreacted alanine was determined at different time intervals.
I I . I n vitro, reaction of alloxan, alloxanic acid and ninh ydrin with blood am ino acids in aerated and non aerated blood
A known weight of alloxan, sodium alloxanate or ninhydrin wras added to known volumes of freshly drawn oxalated blood in glass stoppered tubes and incubated a t 37 °C. At different intervals, samples were withdrawn and pipetted into centrifuge tubes containing ice cooled trichloro-acetic acid solution and the tubes were centrifuged. Knowrn volumes of the supernatant fluid were used for determining the unreacted amino acids. The same reactions were carried out by bubbling air through the reaction medium and the unreacted amino acids were determined at various time.
I I I . Reaction of alloxan with alanine in vitro
Experiments wrere carried out to investigated whether or not the S t r e c k e r reaction takes place in blood between alloxan and alanine. If such reaction does occur, alanine would be oxidatively degraded to acetaldehyde.
Sam ples o f oxalated blood were divided into 3 aliquots and incubated in closed tubes at 37 °C; one w ith known w eight of alloxan, one w ith alloxan together w ith alanine, and the third w ith alanine only. A t different intervals aliquots were rem oved from the reaction m ixtures, and their acetaldehyde contents were determ ined, using the modified procedure o f Stotz8.
I V . Reaction of alloxan and ninhydrin with blood am ino acids in vivo
R ats were intravenously injected with a solution (0.3 ml) containing 60-80 mg of alloxan or 50 to 120 mg ninhydrin per one kg body weight. Blood samples were collected before and at different intervals after the injection, and their amino acid nitrogen contents were determined.
The blood sugar of the rats was estimated before and 24 as well as 48 hours after the injections. The method described by H a s e l w o o d 9 for the deter mination of blood sugar was used.
Results and Discussion Fig. 1 shows th a t in buffered aqueous solutions at pH 7 the degradation of alanine by alloxan or ninhydrin is a slow reaction. Bubbling air through the reaction mixtures enhance greatly the rate of degradation of alanine in presence of alloxan, whereas the rate is slightly affected in presence of ninhydrin. The results also show th a t in case of alloxan the concentration of alanine is unchanged during the first 30 and 10 hours in non-aerated and aerated solutions respectively. On the other hand alloxan changes nearly completely to alloxanic acid within one hour10 in buffered solution of pH 7 as well as in blood in vitro. Therefore, it seemed worth- while to find whether or not alloxanic acid could oxidatively degrades alanine. Fig. 2 shows th at the rate of the reaction of alloxan or sodium alloxanate with alanine is almost the same. Accordingly, one may conclude th a t the reacting oxidising agent in buffered aqueous solution at pH 7 is alloxanic acid and not alloxan. This was confirmed by following the rate of disappearance of alloxan at pH 7 in presence of alanine. The results obtained showed th a t the rate of rearrangement of alloxan to alloxanic acid in presence of alanine is almost the same as th a t obtained previously in absence of alanine10. According to B a d d a r 3-5 compounds containing a carbonyl group attached to strongly negative groups may also give the S t r e c k e r reaction. This may explain why alloxanic acid, degrades alanine. The mechanism of this reaction (which is not the aim of the present work) will be studied later.
Several approaches11-18 were made towards elucidating the relationship between the diabeto genic action of alloxan, its stability and its chemical properties. The main difficulty in studying the S t r e c k e r reaction in blood is due to the lack of suitable analytical m ethods19. In the present work, the new technique developed to study the S t r e c k e r reaction in blood in vitro and in vivo seems to overcome the difficulties encountered in the previous investigations.
The results obtained in vitro (Table I) indicate th a t alloxan, alloxanic acid and ninhydrin degrade amino acids in blood a t a much accelerated rate compared to the reaction in aqueous medium. In 20 minutes about 30% of amino acids originally present in blood disappears. Bubbling air (see Tables II, III , and IV) increases the rate of alloxan as well as alloxanic acid reactions but not th a t of ninhydrin. The products given by alloxan and ninhydrin in the course of S t r e c k e r reaction are different in nature. Ninhydrin is directly involved in a complex form ation20, w'hile alloxan first gives reduction products which in a later stage of the reaction contributes in the formation of m urexide1. The reduction products of alloxantin and dialuric acid are readily oxidised by atmospheric oxygen to regenerate back alloxan21*22. This may explain why bubbling air increases the rate in presence of alloxan, if we suppose th a t in 10 minutes alloxan does not change completely to alloxanic acid. However, the similar changes of amino acids ob tained on addition of alloxan or sodium alloxanate to blood could not be interpreted here because more work is needed to throw more light on the mechanism of the S t r e c k e r degradation found in this investiga tion. In order to determine whether or not the dis appearance of blood amino acids is due to S t r e c k e r reaction, the results obtained (see Table V ) indicate th a t first, blood acetaldehyde increases in samples containing alloxan and this increase is greatly enhanced in those samples containing alloxan plus alanine. Second, the level of blood acetaldehyde remains unchanged when blood was incubated with alanine alone. These results show th at S t r e c k e r de gradation takes place in vitro in presence of alloxan.
T able V. C oncentration o f acetaldehyde in ra t's blood
In vivo experiments (see Table VI ) 30% of blood amino acids of rats receiving alloxan disappears 10 minutes after injection. On the other hand, the concentration of blood amino acids of rats receiving injection of ninhydrin remain unchanged as shown in Table VII . These results also show th a t there is no detectable difference in blood acetaldehyde after injection. This is expected due to the rapid metabo lism of acetaldehyde in blood.
The change in blood sugar concentration as shown in Table V III confirms th a t injection of alloxan induces diabetes in rats, while ninhydrin and alloxanic acids are not diabetogenic but rather toxic.
The S t r e c k e r reaction, therefore, takes place in vivo only by alloxan which is diabetogenic and not by ninhydrin or alloxanic acid both being nondiabetogenic.
The production of diabetes in rats (not rabbits) receiving large doses of dehydroascorbic acid has been reported23 and well confirmed24-26. Also in jection of rats with sodium salt of naphthoquinone sulfonic acid11 causes impairment of carbohydrate metabolism. B r u c k m a n n 11 believes th at the sub stance may be potentially diabetogenic with higher doses, the latter however, are not tolerated by rats for more than one day. Ascorbic acid and naphthoquinone2 have long been known to give the S t r e c k e r reaction in aqueous solutions. Also some mono-N-derivatives of alloxan are diabetogenic11'27, while substitution in the C5 position of alloxan abolishes its activity: Barbituric acid, violuric acid and uramil are in active in inducing diabetes28-29.
These three substances, as judged by their structure, should not give S t r e c k e r reaction as none of them contains the grouping -CO (C H =C H )nCO_ 2.
In view of the above results, the degradation of amino acids by ninhydrin and alloxanic acid in vitro and not in vivo, together with the previous results10 th at alloxan does not change to alloxanic acid in vivo, well illustrate th at conclusions concerning in vivo reactions should always be based on results obtained from experiments carried out on intact animals. Now, could it be possible th a t the S t r e c k e r reaction bears a relationship to the mechanism by which alloxan selectively destroys the beta cells ? At present, at least the two arguments raised by B r u c k m a n n against this possibility are no longer valid. This is because the results obtained in this investigation indicate th at first, alloxan rapidly degrades blood amino acids in intact rats; second, other compounds th at are active agents in the S t r e c k e r reaction in vitro and are not diabetogenic may not obligatory give the same reaction in vivo. This is found the case with ninhydrin and also alloxanic acid. From these findings, we may conclude th a t the Strecker reaction should not be overlooked whenever the mechanism of alloxan diabetes is discussed.
